by
According to the Foreclaro Global Research, the
Global
Nuclear Medicine Market size was valued at USD 6384.2 million in 2024. The report “Global
Nuclear Medicine Market Segmentation By Product Type (Diagnostic
Nuclear Medicine {SPECT Radiopharmaceuticals, PET Radiopharmaceuticals}, Therapeutic
Nuclear Medicine {Alpha Emitters, Beta Emitters}), By Application (Oncology, Cardiology,
Neurology, Thyroid Disorders, Orthopedics), By End User (Hospitals, Diagnostic
Imaging Centers, Research Institutes)- Industry Trends and Forecast to 2033” gives a detailed insight into current market
dynamics and provides analysis on future market growth.
Nuclear medicine is a specialised area of
clinical imaging and remedy that makes use of small quantities of radioactive
materials, called radiopharmaceuticals, to diagnose, monitor, and deal with
diverse diseases, mainly cancer, cardiovascular disorders, and neurological
conditions. By combining useful and anatomical imaging thru technology like
PET, SPECT, and hybrid PET/CT systems, nuclear medication allows early and
noticeably correct detection of disorder procedures on the molecular level. On
the healing side, centered radionuclide therapies, consisting of alpha and beta
emitters, supply localized radiation immediately to diseased tissues, lowering
harm to wholesome cells. Recent improvements consisting of theranostics, novel
radiotracers, and AI integration are riding the sector closer to greater
personalised and specific care. Despite demanding situations like isotope
deliver constraints, excessive costs, and regulatory complexities, nuclear
medication keeps to convert contemporary-day healthcare with the aid of using
imparting extraordinary equipment for early diagnosis, remedy planning, and
disorder management, in the end enhancing affected person results and nice of
lifestyles worldwide.
Have any questions or need more information?
Click the link below to request a sample or make an inquiry before making your
purchase:
https://foreclaroglobalresearch.com/research-report/global-nuclear-medicine-market
Global Nuclear
Medicine Market Report Highlights
· Increasing
worldwide incidence of cancer, cardiovascular, and neurological problems drives
the need for superior imaging and centered radionuclide therapies.
· Strong
shift within the course of theragnostic approaches, combining prognosis and
therapy, specifically in oncology, to customize remedy and enhance outcomes.
· Adoption
of hybrid imaging systems (PET/CT, SPECT/CT), AI integration, and next-generation
radiopharmaceuticals complements diagnostic accuracy and efficiency.
· Asia-Pacific
and Latin America become high-growth markets because of advanced healthcare
infrastructure, growing awareness, and investments in nuclear medicine.
· Key
corporation gamers beef up portfolios and increase market acquire through
acquisitions of radio pharma producers and collaborative R&D.
· High
system and isotope manufacturing costs, regulatory hurdles, and isotope delivery
chain obstacles hold back the quicker adoption globally.
Foreclaro
Global Research has segmented the Nuclear Medicine Market report based on Product
Type, Application, End User Industry, and region:
Nuclear Medicine Market, Product Type Outlook
(Revenue - USD Million, 2020 - 2033)
Diagnostic Nuclear Medicine
·
SPECT
Radiopharmaceuticals
·
PET
Radiopharmaceuticals
Therapeutic Nuclear Medicine
·
Alpha
Emitters
·
Beta
Emitters
Nuclear Medicine Market, Application
Outlook (Revenue - USD Million, 2020 - 2033)
Oncology
Cardiology
Neurology
Thyroid Disorders
Orthopedics
Nuclear Medicine Market, End User
Outlook (Revenue - USD Million, 2020 - 2033)
Hospitals
Diagnostic Imaging Centers
Research Institutes
Nuclear Medicine Market, Regional
Outlook (Revenue - USD Million, 2020 - 2033)
North
America
·
United
States
·
Canada
·
Mexico
Europe
·
United
Kingdom
·
Germany
·
France
·
Spain
·
Italy
·
Rest
of Europe
Asia
Pacific
·
China
·
India
·
Japan
·
Australia
·
South
Korea
·
Rest
of Asia Pacific
Latin
America
·
Brazil
·
Argentina
·
Rest
of Latin America
Middle East
& Africa
·
Saudi
Arabia
·
South
Africa
·
Rest
of MEA
Global Nuclear Medicine Market Key Players
·
GE Healthcare
·
Siemens Healthineers
·
Curium Pharma
·
Lantheus Holdings
·
Bracco Imaging
·
Nordion Inc.
·
Jubilant Pharma
·
China Isotope & Radiation Corporation
·
Cardinal Health
·
Advanced Accelerator
Applications (Novartis)
